Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-24
DOI
10.3389/fphar.2020.00941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the treatment results for Behçet uveitis in patients treated with infliximab and interferon
- (2019) Nilüfer Yalçindag et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- 2018 update of the EULAR recommendations for the management of Behçet’s syndrome
- (2018) Gulen Hatemi et al. ANNALS OF THE RHEUMATIC DISEASES
- Behçet's disease: New insights into pathophysiology, clinical features and treatment options
- (2018) Antonio Greco et al. AUTOIMMUNITY REVIEWS
- Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
- (2018) José Luis Martín-Varillas et al. OPHTHALMOLOGY
- Management of skin, mucosa and joint involvement of Behçet’s syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome
- (2018) Pietro Leccese et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review
- (2018) Shuai Ming et al. Drug Design Development and Therapy
- Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
- (2018) Ana Urruticoechea-Arana et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study
- (2016) Claudia Fabiani et al. CLINICAL RHEUMATOLOGY
- Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
- (2016) Quan Dong Nguyen et al. LANCET
- Adalimumab in Patients with Active Noninfectious Uveitis
- (2016) Glenn J. Jaffe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients
- (2016) Audrey-Elodie Mercier et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2016) BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2016) BMJ-British Medical Journal
- The immunogenetics of Behçet's disease: A comprehensive review
- (2015) Masaki Takeuchi et al. JOURNAL OF AUTOIMMUNITY
- FRI0213 Anti-TNF therapy in refractory uveitis of behcet’s syndrome. A multicenter study of 63 patients:
- (2014) C. Bejerano et al. ANNALS OF THE RHEUMATIC DISEASES
- SAT0148 Short and Long-Term Biological Therapy in Refractory Uveitis of Behcet’S Syndrome. Multicenter Study of 108 Patients
- (2014) V. Calvo-Río et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Behçet's Disease
- (2014) Masaru Takeuchi et al. OPHTHALMOLOGY
- Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients
- (2014) V. Calvo-Rio et al. RHEUMATOLOGY
- 2013 Annual Meeting Abstract Supplement
- (2013) ARTHRITIS AND RHEUMATISM
- Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial
- (2013) Eric B Suhler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behçet Disease Treated with Infliximab
- (2013) Sultan Al Rashidi et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
- (2013) Grace Levy-Clarke et al. OPHTHALMOLOGY
- Behçet's Syndrome
- (2013) Gulen Hatemi et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Current Evidence of Anti-Tumor Necrosis Factor α Treatment Efficacy in Childhood Chronic Uveitis: A Systematic Review and Meta-Analysis Approach of Individual Drugs
- (2013) Gabriele Simonini et al. ARTHRITIS CARE & RESEARCH
- Multicenter Study of Infliximab for Refractory Uveoretinitis in Behçet Disease
- (2012) Hiroshi Goto ARCHIVES OF OPHTHALMOLOGY
- Infliximab and Adalimumab for Uveitis
- (2012) Joseph N. Martel et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- New insights into the pathogenesis of Behçet's disease
- (2011) Marc Pineton de Chambrun et al. AUTOIMMUNITY REVIEWS
- New Insights in the Clinical Understanding of Behçet's Disease
- (2011) Sung Bin Cho et al. YONSEI MEDICAL JOURNAL
- Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy
- (2010) H. Keino et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical Experience with Adalimumab in the Treatment of Ocular Behçet Disease
- (2010) Ahmed Bawazeer et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Switching biologic agents for uveitis
- (2009) N Dhingra et al. EYE
- Ocular Inflammation in Behçet Disease: Incidence of Ocular Complications and of Loss of Visual Acuity
- (2008) R. Oktay Kaçmaz et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started